Stockreport

Hold For Now: Shattuck Labs' SL-172154 Potential In Early Trials [Seeking Alpha]

Shattuck Labs, Inc.  (STTK) 
PDF SL-172154, their flagship candidate, is in Phase 1 trials and shows a promising anti-tumor immune response. The collaboration with Ono Pharmaceutical secures up to $2 [Read more]